SynapDx Corporation closed US $15.4 million in a funding round led by Google Ventures and joined in by Foundation Medical Partners.

The money will be used to finance the SynapDx, which is described as a diagnostics and informatics company dedicated to neurodevelopment disorders in children. The company is presently trying to develop a diagnostic test that will allow doctors to determine autism in children.

With the investment, Google's Andrew Conrad will join the board of directors of SynapDx.

In a statement following the announcement, Conrad said that modern informatics and genomics will be responsible for the "best diagnostics tests of our era."

"Given my prior involvement on Autism Speaks' board, I am well aware of the need for better diagnostics to help clinicians and families get children identified as quickly as possible," he said.

SynapDx CEO Stan Lapidus said that they are excited with Google and Foundation's Medical decision to join their organization because of the transformational opportunity this presents for SynapDx."